TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15157730

Group type: EXPERIMENTAL
Intervention: Fluticasone 88 microg via metered-dose inhaler and Aerochamber, twice daily for 2 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo via metered-dose inhaler and Aerochamber, twice daily for 2 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluticasone 88 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12174401

Group type: EXPERIMENTAL
Intervention: Community intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control county (not specified)
Number of subjects: 0
Study: 9028537

Group type: EXPERIMENTAL
Intervention: Growth hormone (hGH) treatment
Number of subjects: 18
Study: 8503339

Group type: EXPERIMENTAL
Intervention: Flutamide 90 mg/day
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Flutamide 375 mg/day
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Flutamide 750 mg/day
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Flutamide 375 mg/day (hormone-treated patients)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Flutamide 750 mg/day (hormone-treated patients)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Flutamide (all doses)
Number of subjects: 165
Study: 3067610

Group type: EXPERIMENTAL
Intervention: 3 g of L-carnitine by intravenous infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: 0.5 g/kg of ethanol in the form of white wine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ethanol plus carnitine
Number of subjects: 15

Group type: COMPARATOR
Intervention: L-carnitine alone
Number of subjects: 15
Study: 29898710

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for alleviation of postoperative vomiting in children
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Parental expectancy
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Parental anxiety
Number of subjects: 282
Study: 26567593

Group type: EXPERIMENTAL
Intervention: Anaferon (ultra-high dilutions of antibodies to human interferon γ), n=20
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo, n=20
Number of subjects: 40
Study: 25623388

Group type: EXPERIMENTAL
Intervention: Motivational counseling and SMS reminders
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 150
Study: 22888817

Group type: EXPERIMENTAL
Intervention: Mental contrasting
Number of subjects: 467
Study: 16542795

Group type: EXPERIMENTAL
Intervention: 20 Gy radiation therapy (RT)
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: 10 Gy radiation therapy (RT)
Number of subjects: 3706

Group type: COMPARATOR
Intervention: No flank radiation therapy (RT)
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: NWTS-4
Number of subjects: 3706
Study: 12677011

Group type: EXPERIMENTAL
Intervention: Intra-arterial pro-urokinase (r-proUK) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10626776

Group type: EXPERIMENTAL
Intervention: Montgomery Asberg Depression Rating Scale (MADRS)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Hamilton Anxiety Rating Scale (HAM-A)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Symptoms observed
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Symptoms in subjects with fewer than five symptoms
Number of subjects: 512
Study: 8610768

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (transdermal or oral)
Number of subjects: 32
Study: 2277578

Group type: EXPERIMENTAL
Intervention: 0.375% plain marcaine 10 mL to each side (Group B)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.375% plain marcaine with 1:200000 epinephrine 10 mL to each side (Group C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 36
Study: 531512

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 20 mg metoclopramide
Number of subjects: 8
Study: 28400191

Group type: EXPERIMENTAL
Intervention: PCWP ≤ 8 mmHg
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: 8 < PCWP ≤ 11 mmHg
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: PCWP > 11 mmHg
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: PCWP (per mmHg)
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Older age (per year)
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Non-Caucasian race
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Higher PVR (per Woods Unit)
Number of subjects: 743
Study: 25581426

Group type: EXPERIMENTAL
Intervention: Red clover (40 mg dried leaves, 2 capsules daily for 12 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (40 mg starch, 2 capsules daily for 12 weeks)
Number of subjects: 72
Study: 22959576

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (15 mg/kg before surgical incision and 15 mg/kg after protamine neutralization)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20965463

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 1548

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 1548
Study: 18782497

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA; Copaxone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon beta (IFNB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various disease-modifying therapies (DMTs)
Number of subjects: 0
Study: 15741722

Group type: EXPERIMENTAL
Intervention: Teacher-supervised toothbrushing once a day at school with 1,450 ppm fluoride toothpaste
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Teacher-supervised toothbrushing
Number of subjects: 517
Study: 12182252

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg orally every 12 hours with IV rosiglitazone 2 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg orally every 12 hours with oral rosiglitazone 4 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: IV rosiglitazone 2 mg alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral rosiglitazone 4 mg alone
Number of subjects: 12
Study: 10416484

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study: 8562272

Group type: EXPERIMENTAL
Intervention: Lacidipine (calcium-antagonist)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Atenolol (beta-blocker)
Number of subjects: 1000
Study: 1775608

Group type: EXPERIMENTAL
Intervention: Amantadine at 300 mg daily
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Desipramine at 150 mg daily
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 6456165

Group type: EXPERIMENTAL
Intervention: Neurodevelopmental therapy program, three times a week for nine weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20
Study: 31318750

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (635 nm, 15 mW) with standard treatment (rest, icing, compression, elevation)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard treatment (rest, icing, compression, elevation)
Number of subjects: 19
Study: 28651971

Group type: EXPERIMENTAL
Intervention: Daily text messaging intervention focusing on anticipated regret and self-monitoring of PMC
Number of subjects: 124

Group type: COMPARATOR
Intervention: No message (control group)
Number of subjects: 124
Study: 26299751

Group type: EXPERIMENTAL
Intervention: Balance training (BAL) group, 4 weeks indoor and 4 weeks outdoor balance training, 2-hour sessions per week
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (CON) group, 8 weeks upper limb training, same dosage as BAL group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Balance training (BAL) group
Number of subjects: 70
Study: 23718743

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (Voluven™) 10 mL/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ringer's acetate 20 mL/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of hydroxyethyl starch followed by Ringer's acetate
Number of subjects: 10
Study: 22580730

Group type: EXPERIMENTAL
Intervention: FPG in the highest quintile
Number of subjects: 806
Study: 19454549

Group type: EXPERIMENTAL
Intervention: 4‐mg oral nicotine pouch (Zonnic pouch)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nicotine chewing gum
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo pouch
Number of subjects: 30
Study: 17826318

Group type: EXPERIMENTAL
Intervention: Regadenoson (400 mug rapid bolus)
Number of subjects: 784

Group type: COMPARATOR
Intervention: Adenosine
Number of subjects: 784

Group type: EXPERIMENTAL
Intervention: Regadenoson
Number of subjects: 784
Study: 15511297

Group type: EXPERIMENTAL
Intervention: Nicotinic acid
Number of subjects: 0
Study: 11463108

Group type: EXPERIMENTAL
Intervention: Intramuscular arteether (3.2 mg/kg on Day 0, followed by 1.6 mg/kg on Days 1 to 4)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Intravenous quinine dihydrochloride (20 mg of the salt/kg, followed by 10 mg of the salt/kg every 8 hr up to Day 6)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intramuscular arteether
Number of subjects: 102

Group type: COMPARATOR
Intervention: Intravenous quinine dihydrochloride
Number of subjects: 102
Study: 9589523

Group type: EXPERIMENTAL
Intervention: Arm cranking aerobic training program (30 min/session, three times/week, 6 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 12
Study: 8024164

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1,200 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Buflomedil (600 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nifedipine (60 mg/day)
Number of subjects: 45
Study: 2521297

Group type: EXPERIMENTAL
Intervention: Brequinar sodium (various schedules: short-term IV infusion every 3 weeks, weekly, twice weekly, five times daily every 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brequinar sodium (highest dose levels)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brequinar sodium
Number of subjects: 0
Study: 174388

Group type: EXPERIMENTAL
Intervention: Ethanol (1.5 g/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (beverage alone)
Number of subjects: 9
Study: 31384903

Group type: EXPERIMENTAL
Intervention: Sternocleidomastoid flaps
Number of subjects: 58

Group type: COMPARATOR
Intervention: Free flaps
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 28958678

Group type: EXPERIMENTAL
Intervention: Combination antiviral therapy (oseltamivir 75 mg, amantadine 100 mg, ribavirin 600 mg)
Number of subjects: 633

Group type: COMPARATOR
Intervention: Oseltamivir monotherapy
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Combination antiviral therapy
Number of subjects: 633
Study: 26401478

Group type: EXPERIMENTAL
Intervention: Dynamic endoscopy and bimanual-binarial dissection (group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Binarial two-hands dissection using an endoscope holder (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined binarial two- and three-handed dissection with one surgeon guiding the endoscope (group B)
Number of subjects: 0
Study: 24245700

Group type: EXPERIMENTAL
Intervention: Vascularized fibular flap
Number of subjects: 25

Group type: COMPARATOR
Intervention: Soft tissue free flap
Number of subjects: 25
Study: 21194496

Group type: EXPERIMENTAL
Intervention: ALGOS algorithm (case management algorithm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systematic telephone contact
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crisis card
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short letters or postcards
Number of subjects: 0
Study: 18337052

Group type: EXPERIMENTAL
Intervention: Counselling
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Leaflet
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study: 16595210

Group type: EXPERIMENTAL
Intervention: Pronuclear morphology (group 1)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Early cleavage status (group 2)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Subgroup A zygotes from each group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Subgroup C zygotes from each group
Number of subjects: 330
Study: 12939417

Group type: EXPERIMENTAL
Intervention: Topiramate (maximum tolerated dose up to 800 mg/day)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 11032270

Group type: EXPERIMENTAL
Intervention: Clonidine (150 microg) added to ropivacaine (40 ml 0.75%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (1 ml) added to ropivacaine (40 ml 0.75%)
Number of subjects: 50
Study: 8822590

Group type: EXPERIMENTAL
Intervention: 8 mmol MgSO4 intravenous bolus over 15 min followed by 3 mmol MgSO4/h
Number of subjects: 14
Study: 1427457

Group type: EXPERIMENTAL
Intervention: Subcutaneously administered calcium heparin (every 8 h)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intravenous sodium heparin
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Subcutaneously administered calcium heparin
Number of subjects: 59
Study: 4084435

Group type: EXPERIMENTAL
Intervention: Construct group (psychological reconstruction programme)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Technique group (behaviour modification for fluent speech)
Number of subjects: 48
Study: 29572087

Group type: EXPERIMENTAL
Intervention: Dual-source computed tomography (CT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no preimplant knowledge of venous anatomy)
Number of subjects: 54
Study: 27454383

Group type: EXPERIMENTAL
Intervention: Low-dose AZD9773
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: High-dose AZD9773
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 24749369

Group type: EXPERIMENTAL
Intervention: UC‐MSCs adjuvant treatment group (n=17)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional treatment group (control group, n=20)
Number of subjects: 37
Study: 22971864

Group type: EXPERIMENTAL
Intervention: High-dose oral Acyclovir
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral Erythromycin (standard dose)
Number of subjects: 42
Study: 20159122

Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase inhibitors
Number of subjects: 44

Group type: COMPARATOR
Intervention: No drug
Number of subjects: 44
Study: 19065363

Group type: EXPERIMENTAL
Intervention: Dinoprostone Slow Release Pessary (Propess)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Gel (Prostin)
Number of subjects: 120
Study: 16132903

Group type: EXPERIMENTAL
Intervention: Single-dose lenograstim (10 microg/kg once a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Split-dose lenograstim (5 microg/kg twice a day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single-dose lenograstim
Number of subjects: 40

Group type: COMPARATOR
Intervention: Split-dose lenograstim
Number of subjects: 40
Study: 12193081

Group type: EXPERIMENTAL
Intervention: Intracoronary BQ‐123 (6 micromol)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 22
Study: 9457019

Group type: EXPERIMENTAL
Intervention: Headgear
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fränkel function regulator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late childhood treatment
Number of subjects: 0
Study: 7614494

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nipradilol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 26
Study: 2694825

Group type: EXPERIMENTAL
Intervention: Mecobalamin (500 gamma i.m., 3 times a week for 4 weeks)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mecobalamin administered group
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non-administered group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Overall bladder pressure
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Overall maximum urethral pressure
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Patients with residual urine less than 50 ml
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Patients with residual urine reduced to less than 50 ml at 3 months
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison between mecobalamin and non-administered groups
Number of subjects: 17
Study: 65508

Group type: EXPERIMENTAL
Intervention: Cromoglycate (cromolyn sodium)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combined regimen (cromoglycate and theophylline)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Theophylline and combined regimen
Number of subjects: 28
Study: 6976790

Group type: EXPERIMENTAL
Intervention: Di-isopropyl phenol (Diprivan) 2.0 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Di-isopropyl phenol (Diprivan) <1.75 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Di-isopropyl phenol (Diprivan) 1.5 - 2.0 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Di-isopropyl phenol (Diprivan) 2.5 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Di-isopropyl phenol (Diprivan) (any dose)
Number of subjects: 0
Study: 30696552

Group type: EXPERIMENTAL
Intervention: Toothpaste containing enzymes and proteins
Number of subjects: 229

Group type: COMPARATOR
Intervention: Commercial control toothpaste
Number of subjects: 229
Study: 29482632

Group type: EXPERIMENTAL
Intervention: Brief advice
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Standard BI (NIAAA Clinician's Guide)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MI-enhanced BI
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All three BI protocols
Number of subjects: 45
Study: 26852138

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 24212920

Group type: EXPERIMENTAL
Intervention: Music-based multitask training (1-hour supervised group classes once weekly for 6 months)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Music-based multitask training
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (delayed intervention, maintained usual lifestyle habits)
Number of subjects: 134
Study: 22473508

Group type: EXPERIMENTAL
Intervention: Compact Bolus (CB) protocol: iomeprol 400mgI/mL, 100 mL, 4 mL/sec
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard Bolus (SB) protocol: iomeprol 300mgI/mL, 134 mL, 4 mL/sec
Number of subjects: 64
Study: 20854047

Group type: EXPERIMENTAL
Intervention: Aclidinium 200 μg
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 μg
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Aclidinium 200 μg and Tiotropium 18 μg
Number of subjects: 115
Study: 17986038

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia with midazolam, ketamine, and propofol (MKP group)
Number of subjects: 655

Group type: COMPARATOR
Intervention: General anesthesia with propofol, vecuronium, and isoflurane (GET group)
Number of subjects: 655
Study: 16301368

Group type: EXPERIMENTAL
Intervention: Orally disintegrating technology (ODT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional tablet
Number of subjects: 36
Study: 11948884

Group type: EXPERIMENTAL
Intervention: AngioSeal (AS)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: VasoSeal (VS)
Number of subjects: 157
Study: 9719052

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (20 mmol/d magnesium in the form of magnesium oxide)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control period (no magnesium supplementation)
Number of subjects: 60
Study: 7544554

Group type: EXPERIMENTAL
Intervention: Serotonin adipinate (5 to 20 mg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Traditional drugs (proserine, pituitrin, cerucal)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Serotonin adipinate
Number of subjects: 95
Study: 2782569

Group type: EXPERIMENTAL
Intervention: 150 ml water 2 hours before surgery
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 150 ml water 2 hours before surgery + intramuscular morphine 0.15 mg/kg and promethazine 0.5 mg/kg one hour before operation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (overnight fast)
Number of subjects: 150
Study: 906892

Group type: EXPERIMENTAL
Intervention: Prophylactic cerebrospinal irradiation
Number of subjects: 22

Group type: COMPARATOR
Intervention: No prophylactic cerebrospinal irradiation (Control)
Number of subjects: 22
Study: 31891295

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ibuprofen 200 mg/Acetaminophen 216.7 mg
Number of subjects: 102
Study: 28013387

Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant extract (CurraNZ™) 600 mg day‐1
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant extract (CurraNZ™) 900 mg day‐1
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no NZBC)
Number of subjects: 15
Study: 25976576

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100mg, twice a day for eight weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (twice a day for eight weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Coenzyme Q10 and Placebo
Number of subjects: 52
Study: 24021291

Group type: EXPERIMENTAL
Intervention: Sodium ferric gluconate complex (SFGC) infused IV at 125 mg over 10 minutes (Study 1)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sodium ferric gluconate complex (SFGC) infused IV at 62.5 mg over 30 minutes (Study 2)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Transferrin-bound iron (TBI) from SFGC (Study 1)
Number of subjects: 240
Study: 21300704

Group type: EXPERIMENTAL
Intervention: Mild CKD (60-90 mL/min/1.73 m²)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe CKD (<60 mL/min/1.73 m²)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Non-CKD (≥90 mL/min/1.73 m²)
Number of subjects: 180